Cargando…

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)

Effective quality assurance is essential in any screening programme. This article provides a unique insight into key quality indicators of five rounds of the first population-based colorectal cancer screening programme implemented in Spain (2000–2012), providing the results according to the type of...

Descripción completa

Detalles Bibliográficos
Autores principales: Binefa, Gemma, Garcia, Montse, Milà, Núria, Fernández, Esteve, Rodríguez-Moranta, Francisco, Gonzalo, Núria, Benito, Llúcia, Clopés, Ana, Guardiola, Jordi, Moreno, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726304/
https://www.ncbi.nlm.nih.gov/pubmed/26787510
http://dx.doi.org/10.1038/srep19532
_version_ 1782411793204772864
author Binefa, Gemma
Garcia, Montse
Milà, Núria
Fernández, Esteve
Rodríguez-Moranta, Francisco
Gonzalo, Núria
Benito, Llúcia
Clopés, Ana
Guardiola, Jordi
Moreno, Víctor
author_facet Binefa, Gemma
Garcia, Montse
Milà, Núria
Fernández, Esteve
Rodríguez-Moranta, Francisco
Gonzalo, Núria
Benito, Llúcia
Clopés, Ana
Guardiola, Jordi
Moreno, Víctor
author_sort Binefa, Gemma
collection PubMed
description Effective quality assurance is essential in any screening programme. This article provides a unique insight into key quality indicators of five rounds of the first population-based colorectal cancer screening programme implemented in Spain (2000–2012), providing the results according to the type of screening (prevalent or first screen and incident or subsequent screen) and test (guaiac or immunochemical). The total crude participation rate increased from 17.2% (11,011) in the first round to 35.9% (22,988) in the last one. Rescreening rate was very high (88.6% in the fifth round). Positivity rate was superior with the faecal immunochemical test (6.2%) than with the guaiac-based test (0.7%) (p < 0.0001) and detection rates were also better with the immunochemical test. The most significant rise in detection rate was observed for high risk adenoma in men (45.5 per 1,000 screened). Most cancers were diagnosed at an early stage (61.4%) and there was a statistically significant difference between those detected in first or subsequent screening (52.6% and 70.0% respectively; p = 0.024). The availability of these results substantially improves data comparisons and the exchange of experience between screening programmes.
format Online
Article
Text
id pubmed-4726304
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47263042016-01-27 Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012) Binefa, Gemma Garcia, Montse Milà, Núria Fernández, Esteve Rodríguez-Moranta, Francisco Gonzalo, Núria Benito, Llúcia Clopés, Ana Guardiola, Jordi Moreno, Víctor Sci Rep Article Effective quality assurance is essential in any screening programme. This article provides a unique insight into key quality indicators of five rounds of the first population-based colorectal cancer screening programme implemented in Spain (2000–2012), providing the results according to the type of screening (prevalent or first screen and incident or subsequent screen) and test (guaiac or immunochemical). The total crude participation rate increased from 17.2% (11,011) in the first round to 35.9% (22,988) in the last one. Rescreening rate was very high (88.6% in the fifth round). Positivity rate was superior with the faecal immunochemical test (6.2%) than with the guaiac-based test (0.7%) (p < 0.0001) and detection rates were also better with the immunochemical test. The most significant rise in detection rate was observed for high risk adenoma in men (45.5 per 1,000 screened). Most cancers were diagnosed at an early stage (61.4%) and there was a statistically significant difference between those detected in first or subsequent screening (52.6% and 70.0% respectively; p = 0.024). The availability of these results substantially improves data comparisons and the exchange of experience between screening programmes. Nature Publishing Group 2016-01-20 /pmc/articles/PMC4726304/ /pubmed/26787510 http://dx.doi.org/10.1038/srep19532 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Binefa, Gemma
Garcia, Montse
Milà, Núria
Fernández, Esteve
Rodríguez-Moranta, Francisco
Gonzalo, Núria
Benito, Llúcia
Clopés, Ana
Guardiola, Jordi
Moreno, Víctor
Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title_full Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title_fullStr Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title_full_unstemmed Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title_short Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
title_sort colorectal cancer screening programme in spain: results of key performance indicators after five rounds (2000–2012)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726304/
https://www.ncbi.nlm.nih.gov/pubmed/26787510
http://dx.doi.org/10.1038/srep19532
work_keys_str_mv AT binefagemma colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT garciamontse colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT milanuria colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT fernandezesteve colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT rodriguezmorantafrancisco colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT gonzalonuria colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT benitollucia colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT clopesana colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT guardiolajordi colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012
AT morenovictor colorectalcancerscreeningprogrammeinspainresultsofkeyperformanceindicatorsafterfiverounds20002012